Search
Search
This series is sponsored by Glaukos
02.16.26
Brandon D. Ayres, MD, continues this series exploring the best practices in keratoconus management with the discussion of the recent FDA approval of Epioxa, an advancement in corneal cross-linking for the treatment of keratoconus. Kenneth Beckman, MD, explains what excites him about Epioxa and how it can improve patient comfort and minimize recovery time. The two surgeons also review the role of supplemental oxygen during the procedure and review the Phase 3 pivotal trial data behind Epioxa.
[Test Your Knowledge HERE]
Sponsored by Glaukos
02.16.26
Evolving the Game Plan: Shifting to Epithelium-On Cross-Linking for KeratoconusBrandon D. Ayres, MD; and Kenneth Beckman, MD
Sponsored by Glaukos
10.29.25
Boost Your Keratoconus Cross-linking Game: Oxygen as the MVPBrandon D. Ayres, MD; and Tomas Navratil, PhD
Sponsored by Glaukos
08.01.25
Use Your Dream Team to Execute Your Keratoconus StrategyBrandon D. Ayres, MD; Susan DeGroot, MBA; and Vivian Cole, BA
Sponsored by Glaukos
03.19.25
Establish a Game Plan for Treating Bilateral KeratoconusBrandon D. Ayres, MD; and John P. Berdahl, MD
Sponsored by Glaukos
01.16.25
Optimizing Your Keratoconus Management PlaybookBrandon D. Ayres, MD; and Eva Kim, MD
Sponsored by Glaukos
11.05.24
Drafting Your Keratoconus QuarterbackBrandon D. Ayres, MD; and Priya M. Mathews, MD, MPH
Sponsored by Glaukos